LMED (LataMed AI) Earnings Yield (Joel Greenblatt) %: -0.19% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LMED LataMed AI Corp LMED
23 GF Score
Price $0.42
! 2 Warning Signs
View Full Analysis

What is LataMed AI Earnings Yield (Joel Greenblatt) %?

LataMed AI LMED -5.52% 23 Earnings Yield (Joel Greenblatt) % is -0.19% as of Jun. 2026. GuruFocus rates LMED with a GF Score™ of 23/100. The stock has 2 warning signs investors should review. Among 2,909 Software companies, LataMed AI ranks worse than 62.19% on this metric.

LataMed AI's Enterprise Value for the quarter that ended in Jun. 2026 was $132.73 Mil. LataMed AI's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.26 Mil. LataMed AI's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was -0.19%.

The historical rank and industry rank for LataMed AI's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

LMED' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -0.21   Med: 0   Max: 0
Current: -0.21

LMED's Earnings Yield (Joel Greenblatt) % is ranked worse than
62.19% of 2909 companies
in the Software industry
Industry Median: 1.95 vs LMED: -0.21

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. LataMed AI's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


LataMed AI  (OTCPK:LMED) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


LataMed AI Earnings Yield (Joel Greenblatt) % Related Terms


LataMed AI Earnings Yield (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for LataMed AI's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LataMed AI Earnings Yield (Joel Greenblatt) % Chart

LataMed AI Annual Data
Trend Dec23 Dec24 Dec25
Earnings Yield (Joel Greenblatt) %
-8.49 -26.53 -0.59

LataMed AI Quarterly Data
Sep09 Sep10 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.91 -4.29 -0.59 -0.29 -0.19

LMED vs RYDE, RDZN, DMRC: Earnings Yield (Joel Greenblatt) % Comparison

For the Software - Application subindustry, LataMed AI's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LataMed AI Earnings Yield (Joel Greenblatt) % vs Software Industry

For the Software industry and Technology sector, LataMed AI's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where LataMed AI's Earnings Yield (Joel Greenblatt) % falls into.


LMED
23GF Score
LataMed AI Corp LMED
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LataMed AI Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

LataMed AIs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-0.172/29.19234968
=-0.59 %

LataMed AI's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.26 Mil.


What does a Earnings Yield (Joel Greenblatt) % of -0.19% mean?
LataMed AI (LMED) has a Earnings Yield (Joel Greenblatt) % of -0.19% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on LataMed AI and its competitors. According to the industry distribution chart, LataMed AI ranks #1809 out of 2909 companies in the Software industry, placing it in the top 62.2%.
Is LataMed AI's Earnings Yield (Joel Greenblatt) % too high?
LataMed AI's current Earnings Yield (Joel Greenblatt) % is -0.19%. Based on the distribution chart, LataMed AI ranks #1809 out of 2909 companies in the Software industry, which is below the industry midpoint. Overall, LataMed AI has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does LataMed AI's Earnings Yield (Joel Greenblatt) % compare to RYDE and RDZN?
According to the Software industry distribution chart, LataMed AI ranks #1809 out of 2909 companies for Earnings Yield (Joel Greenblatt) %. This places LataMed AI in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 1.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Software company?
The median Earnings Yield (Joel Greenblatt) % among Software companies is 1.95, based on 2,909 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on LataMed AI and its competitors. For the Software industry, the median Earnings Yield (Joel Greenblatt) % is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LataMed AI's current Earnings Yield (Joel Greenblatt) % is -0.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LataMed AI stock overvalued right now?
LataMed AI (LMED) has a current Earnings Yield (Joel Greenblatt) % of -0.19%. The current Earnings Yield (Joel Greenblatt) % is -0.19%. LataMed AI's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For LataMed AI (LMED), the current Earnings Yield (Joel Greenblatt) % is -0.19% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LataMed AI Business Description

Address Av. Romulo Gallegos con Av. Las Palmas, Edif. Torre Gerencial Los Andes, Caracas, VEN, 1071
LataMed AI Corp is a technology company focused on the development and deployment of artificial intelligence-driven healthcare solutions across Latin America. Its healthcare platform includes AI-enabled analytics, telehealth infrastructure, and coordinated care systems designed to support healthcare delivery in emerging markets. The company develops digital infrastructure for patient prioritization, clinical workflow management, telehealth access, care coordination, and healthcare system operations. It holds issued patents for its core AI modules-CardioAI, PulmoAI, and NeuroAI-which deliver predictive analytics for cardiovascular, pulmonary, and neurological disease detection and management.
23GF Score

Get the complete analysis for LMED

Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price